Cardinal Health anesthesia kits draw most serious FDA warning; Joint replacement use increases in younger patients;

@FierceMedDev: Hologic slashes outlook as losses widen. Report | Follow @FierceMedDev

@MarkHFierce: Dx test maker Quidel now owns BioHelix, for $10M, plus milestone payments. Item | Follow @MarkHFierce

 @DamianFierce: Medtronic won FDA approval for two new cardiac devices. Story | Follow @DamianFierce

> The FDA has placed its most serious warning on Cardinal Health's ($CAH) recall of anesthesia kits designed for presurgery. More

> The lack of child-sized medical devices can make it difficult for pediatric patients to safely endure much-needed procedures. Article

> The hairlike structures on bats' tongues, used to lap up nectar, could be a good model for future medical devices. Story

> Hill-Rom Holdings ($HRC) obtained 510(k) clearance to market a new airway clearance device designed, in part, to clear mucus from the lungs and prevent a lung collapse. Item

> Surgeons are increasingly using joint replacement implants in younger patients. Story

> Medical equipment donations to developing countries either end up unused or broken due to lack of training, spare parts or electrical capacity to handle them. Story

Biotech News

@FierceBiotech: NGM raises $13M for cardio/metabolic R&D work. Item | Follow @FierceBiotech

@JohnCFierce: Astellas, VCs stake virtual biotech spinout with $15M and a PhII program. Release | Follow @JohnCFierce

@RyanMFierce: Pfizer opts to keep running Accelrys software in its labs. Article | Follow @RyanMFierce

> GlaxoSmithKline's "independent experts" start to hand out keys to its data vault. Story

> Baxter adds Gammagard to growing roster of PhIII Alzheimer's failures. Article

> Celgene nabs another round of promising pivotal apremalist data for psoriatic arthritis. Report

Pharma News

@FiercePharma: Lilly salesforce cuts to be deeper than expected, Indy Biz Journal says: 1,624 jobs, or 40%, not 30%. Report | Follow @FiercePharma

@EricPFierce: Eli Lilly's CEO John C. Lechleiter will have surgery and be out for some weeks. Release | Follow @EricPFierce

> Don't confuse Kadcyla with Herceptin, FDA says. More

> Lilly CEO set for surgery on dilated aorta; CFO steps up temporarily. Article

> DEA finally acts on Belviq, clearing Arena for diet drug's launch. Article

Pharma Manufacturing News

> Pfizer sells Viagra online to take away play by counterfeiters. Item

> Novo investing $67M in Denmark plant. Article

> J&J dealing with OTC manufacturing issues on 3 continents. Story

> Sagent buys full control of China plant. News

Biotech Research News

 @EmilyMFierce: New molecule could be potential therapy for muscular dystrophy. More | Follow @EmilyMFierce

> Inhibiting a protein could provide new avenue for antidepressant drug development. Report

> Genetic "switch" could halt aggressive cancer growth. More

> Scientists create more accurate animal model of Type 2 diabetes. Story

> Mayo Clinic develops drug that stops growth of kidney cancer. Article

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.